These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16269425)

  • 1. Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations.
    Aries PM; Hellmich B; Voswinkel J; Both M; Nölle B; Holl-Ulrich K; Lamprecht P; Gross WL
    Ann Rheum Dis; 2006 Jul; 65(7):853-8. PubMed ID: 16269425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations.
    Holle JU; Dubrau C; Herlyn K; Heller M; Ambrosch P; Noelle B; Reinhold-Keller E; Gross WL
    Ann Rheum Dis; 2012 Mar; 71(3):327-33. PubMed ID: 22021864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients.
    Brihaye B; Aouba A; Pagnoux C; Cohen P; Lacassin F; Guillevin L
    Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S23-7. PubMed ID: 17428359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study.
    Martinez Del Pero M; Chaudhry A; Jones RB; Sivasothy P; Jani P; Jayne D
    Clin Otolaryngol; 2009 Aug; 34(4):328-35. PubMed ID: 19673980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report.
    Ooka S; Maeda A; Ito H; Omata M; Yamada H; Ozaki S
    Mod Rheumatol; 2009; 19(1):80-3. PubMed ID: 18806927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab for treatment-resistant extensive Wegener's granulomatosis--additive effects of a maintenance treatment with leflunomide.
    Henes JC; Fritz J; Koch S; Klein R; Horger M; Risler T; Kanz L; Koetter I
    Clin Rheumatol; 2007 Oct; 26(10):1711-5. PubMed ID: 17502992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
    Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
    J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis.
    Taylor SR; Salama AD; Joshi L; Pusey CD; Lightman SL
    Arthritis Rheum; 2009 May; 60(5):1540-7. PubMed ID: 19404964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wegener's granulomatosis effectively treated with rituximab: a case study.
    Kowalewska B; Szechiński J; Roszkowska E
    Pol Arch Med Wewn; 2008 Jun; 118(6):381-5. PubMed ID: 18619196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener's).
    Recillas-Gispert C; Serna-Ojeda JC; Flores-Suárez LF
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2279-84. PubMed ID: 26507398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations.
    Seo P; Specks U; Keogh KA
    J Rheumatol; 2008 Oct; 35(10):2017-23. PubMed ID: 18688911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial.
    Keogh KA; Ytterberg SR; Fervenza FC; Carlson KA; Schroeder DR; Specks U
    Am J Respir Crit Care Med; 2006 Jan; 173(2):180-7. PubMed ID: 16224107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab with or without a conventional maintenance agent in the treatment of relapsing granulomatosis with polyangiitis (Wegener's): a retrospective single-center study.
    Azar L; Springer J; Langford CA; Hoffman GS
    Arthritis Rheumatol; 2014 Oct; 66(10):2862-70. PubMed ID: 24943239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.
    Calich AL; Puéchal X; Pugnet G; London J; Terrier B; Charles P; Mouthon L; Guillevin L;
    J Autoimmun; 2014 May; 50():135-41. PubMed ID: 24703438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab in refractory ophthalmic Wegener's granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effective.
    Joshi L; Lightman SL; Salama AD; Shirodkar AL; Pusey CD; Taylor SR
    Ophthalmology; 2011 Dec; 118(12):2498-503. PubMed ID: 21907416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory Wegener's granulomatosis responds to tumor necrosis factor blockade.
    Kleinert J; Lorenz M; Köstler W; Hörl W; Sunder-Plassmann G; Soleiman A
    Wien Klin Wochenschr; 2004 May; 116(9-10):334-8. PubMed ID: 15237661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response.
    Omdal R; Wildhagen K; Hansen T; Gunnarsson R; Kristoffersen G
    Scand J Rheumatol; 2005; 34(3):229-32. PubMed ID: 16134730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapsed Wegener's granulomatosis after rituximab therapy--B cells are present in new pathological lesions despite persistent 'depletion' of peripheral blood.
    Ferraro AJ; Smith SW; Neil D; Savage CO
    Nephrol Dial Transplant; 2008 Sep; 23(9):3030-2. PubMed ID: 18586761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory Wegener's granulomatosis: effect of rituximab on granulomatous bilateral orbital involvement.
    Avshovich N; Boulman N; Slobodin G; Zeina AR; Rosner I; Rozenbaum M
    Isr Med Assoc J; 2009 Sep; 11(9):566-8. PubMed ID: 19960854
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of orbital inflammation with rituximab in Wegener's granulomatosis.
    Baslund B; Wiencke AK; Rasmussen N; Faurschou M; Toft PB
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S7-10. PubMed ID: 22272561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.